| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/30/2008 | CN101232884A Quinoline derivatives as antibacterial agents |
| 07/30/2008 | CN101230038A Pyridine carboxamide derivatives and their use as pesticides |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/30/2008 | CN100406524C Sulfoxider or sulfones gralted onto polymers |
| 07/30/2008 | CN100406461C Sulphur containing heterocyclic and naphthalimides compound and use thereof |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406436C Crystal forms of atorvastatin hemi-calcium and processes for preparing atorvastatin hemi-calcium forms IX |
| 07/30/2008 | CN100406009C Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2323315C Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/24/2008 | WO2008089015A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | WO2008088969A2 Synthesis of selected stereoisomers of certain substituted alcohols |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087514A2 Hdac inhibitors |
| 07/24/2008 | WO2008086733A1 New pharmaceutical composition |
| 07/24/2008 | WO2008086729A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis |
| 07/24/2008 | WO2008065068A3 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2007120364A3 Metabolites of wortmannin analogs and methods of using the same |
| 07/24/2008 | WO2007080401A8 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/24/2008 | US20080177086 Sulfonamide Derivatives of Xanthene Compounds |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080176903 Novel Compounds with Analgesic Effect |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176896 Modulators of cellular adhesion |
| 07/24/2008 | US20080176876 Substituted 2-Alkyl Quinazolinone Derivatives as Parp Inhibitors |
| 07/24/2008 | US20080176864 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy |
| 07/24/2008 | US20080176863 Capped pyrazinoylguanidine sodium channel blockers |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | CA2674946A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/23/2008 | EP1947100A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 07/23/2008 | EP1947091A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945632A1 Heterocyclic modulators of atp-binding cassette transporters |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945627A1 Pyrimidine derivatives for the treatment of cancer |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945213A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 07/23/2008 | EP1735285B1 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 07/23/2008 | EP1685108B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 07/23/2008 | EP1615909B1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/23/2008 | EP1567489B1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | CN101228154A Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 07/23/2008 | CN101228140A Imidazole-amino acid derivatives and related compounds synthetic method |
| 07/23/2008 | CN101228133A Heteroaroyl-substituted serineamides |
| 07/23/2008 | CN100404544C 9-ketospinosyn derivatives |
| 07/23/2008 | CN100404530C Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/23/2008 | CN100404527C Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404509C Isoquinoline compound, preparation method and application of salt thereof |
| 07/23/2008 | CN100404508C Tetrahydroquinoline derivatives |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402675 Process for the synthesis of amine ethers from secondary amino oxides |
| 07/22/2008 | US7402639 Narrow moleculae weight distribution; addition piolymers; process control |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402589 such as 1-(4-Fluorophenyl)-1-{2-[(1S)-2-hydroxy-1,2-dimethyl-propylamino]-pyrimidin-4-yl}-3-o-tolyl-urea; Interleukin-1, Cycloxygenase-2, Tumor Necrosis Factor- alpha antagonist; antiinflammatory agent; rheumatoid arthritis or osteoarthritis |
| 07/22/2008 | US7402588 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2238171C Quinoline derivatives as nk3 antagonists |
| 07/17/2008 | WO2008084671A1 Process for producing 1-substituted-2-pyridone-3-carboxylic acid derivative |
| 07/17/2008 | WO2008084218A1 Benzazole derivatives for the treatment of inflammations |
| 07/17/2008 | WO2008084073A1 Heteroaryl-substituted serine amides |
| 07/17/2008 | WO2008083729A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | WO2008083551A1 4-substituted oxyphenyl quinolines, intermediate compounds, preparation methods and uses thereof |